Skip to Content

Clindamycin Phosphate Injection

Last Updated: December 14, 2018
Status: Current

Products Affected - Description
    • Cleocin injection, Pfizer, 150 mg/mL, 2 mL ADD-Vantage vial, 25 count, NDC 00009-6582-01
    • Cleocin injection, Pfizer, 150 mg/mL, 4 mL ADD-Vantage vial, 25 count, NDC 00009-3124-03
    • Cleocin injection, Pfizer, 150 mg/mL, 6 mL ADD-Vantage vial, 25 count, NDC 00009-3447-03
    • Cleocin injection, Pfizer, 300 mg/50 mL, in 5% dextrose premixed bag, 24 count, NDC 00009-3381-02
    • Cleocin injection, Pfizer, 600 mg/50 mL, in 5% dextrose premixed bag, 24 count, NDC 00009-3375-02
    • Cleocin injection, Pfizer, 900 mg/50 mL, in 5% dextrose premixed bag, 24 count, NDC 00009-3382-02
    • Clindamycin phosphate injection, Akorn, 600 mg/50 mL, premixed bottle, 1 count, NDC 17478-0121-50
    • Clindamycin phosphate injection, Akorn, 900 mg/50 mL, premixed bottle, 1 count, NDC 17478-0122-50
    • Clindamycin phosphate injection, Alvogen, 150 mg/mL, 2 mL ADD-Vantage vial, 25 count, NDC 47781-1619-69
    • Clindamycin phosphate injection, Alvogen, 150 mg/mL, 4 mL ADD-Vantage vial, 25 count, NDC 44781-1620-69
    • Clindamycin phosphate injection, Alvogen, 150 mg/mL, 6 mL ADD-Vantage vial, 25 count, NDC 47781-1621-69
Reason for the Shortage
    • Alvogen did not provide a reason for the shortage.
    • Akorn did not provide a reason for the shortage.
    • Baxter has clindamycin injection available.
    • Fresenius Kabi did not provide a reason for the shortage.
    • Pfizer did not provide a reason for the shortages. Pfizer discontinued Cleocin premixed bags in 2018.
    • Sagent has clindamycin injection available.
    • Sandoz has clindamycin injection available.
Available Products
    • Cleocin injection, Pfizer, 150 mg/mL, 2 mL vial, 25 count, NDC 00009-0870-26
    • Cleocin injection, Pfizer, 150 mg/mL, 4 mL vial, 25 count, NDC 00009-0775-26
    • Cleocin injection, Pfizer, 150 mg/mL, 6 mL vial, 25 count, NDC 00009-0902-18
    • Cleocin injection, Pfizer, 150 mg/mL, 60 mL bulk vial, 5 count, NDC 00009-0728-09
    • Clindamycin phosphate injection, Akorn, 300 mg/50 mL, in 5% dextrose premixed bottle, 1 count, NDC 17478-0120-50
    • Clindamycin phosphate injection, Alvogen, 150 mg/mL, 2 mL vial, 25 count, NDC 47781-0459-68
    • Clindamycin phosphate injection, Alvogen, 150 mg/mL, 4 mL vial, 25 count, NDC 47781-0460-68
    • Clindamycin phosphate injection, Alvogen, 150 mg/mL, 6 mL vial, 25 count, NDC 44781-0461-68
    • Clindamycin phosphate injection, Alvogen, 150 mg/mL, 60 mL bulk vial, 1 count, NDC 47781-0465-70
    • Clindamycin phosphate injection, Baxter, 300 mg/50 mL, in 0.9% sodium chloride premixed container, 24 count, NDC 00338-9545-24
    • Clindamycin phosphate injection, Baxter, 300 mg/50 mL, in 5% dextrose premixed container, 24 count, NDC 00338-3410-24
    • Clindamycin phosphate injection, Baxter, 600 mg/50 mL, in 0.9% sodium chloride premixed container, 24 count, NDC 00338-9549-24
    • Clindamycin phosphate injection, Baxter, 600 mg/50 mL, in 5% dextrose premixed container, 24 count, NDC 00338-3612-24
    • Clindamycin phosphate injection, Baxter, 900 mg/50 mL, in 0.9% sodium chloride premixed container, 24 count, NDC 00338-9553-24
    • Clindamycin phosphate injection, Baxter, 900 mg/50 mL, in 5% dextrose premixed container, 24 count, NDC 00338-3814-24
    • Clindamycin phosphate injection, Fresenius Kabi, 150 mg/mL, 2 mL vial, 25 count, NDC 63323-0282-02
    • Clindamycin phosphate injection, Fresenius Kabi, 150 mg/mL, 4 mL vial, 25 count, NDC 63323-0282-04
    • Clindamycin phosphate injection, Fresenius Kabi, 150 mg/mL, 6 mL vial, 25 count, NDC 63323-0282-06
    • Clindamycin phosphate injection, Fresenius Kabi, 150 mg/mL, 60 mL vial, 1 count, NDC 63323-0282-60
    • Clindamycin phosphate injection, Sagent, 150 mg/mL, 2 mL vial, 25 count, NDC 25021-0115-02
    • Clindamycin phosphate injection, Sagent, 150 mg/mL, 4 mL vial, 25 count, NDC 25021-0115-04
    • Clindamycin phosphate injection, Sagent, 150 mg/mL, 6 mL vial, 25 count, NDC 25021-0115-06
    • Clindamycin phosphate injection, Sagent, 150 mg/mL, 60 mL bulk vial, 1 count, NDC 25021-0115-51
    • Clindamycin phosphate injection, Sandoz, 300 mg/50 mL, in 5% dextrose premixed container, 24 count, NDC 00781-3288-09
    • Clindamycin phosphate injection, Sandoz, 600 mg/50 mL, in 5% dextrose premixed container, 24 count, NDC 00781-3289-09
    • Clindamycin phosphate injection, Sandoz, 900 mg/50 mL, in 5% dextrose premixed container, 24 count, NDC 00781-3290-09

Estimated Resupply Dates

    • Akorn has clindamycin 600 mg/50 mL and 900 mg/50 mL in 5% dextrose premixes on back order and the company cannot estimate a release date.
    • Alvogen has clindamycin 150 mg/mL 2 mL, 4 mL, and 6 mL ADD-Vantage vials on back order and the company estimates a release date of 2nd quarter 2019.
    • Pfizer has Cleocin 150 mg/mL 2 mL, 4 mL, and 6 mL ADD-Vantage vials on back order and the company estimates a release date of 3rd quarter 2019.

Updated

Updated December 14, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created June 13, 2013 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide